4.3 Article

Association of visit-to-visit glycemic variability with risk of cardiovascular diseases in high-risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial

Journal

JOURNAL OF DIABETES INVESTIGATION
Volume 12, Issue 12, Pages 2190-2196

Publisher

WILEY
DOI: 10.1111/jdi.13597

Keywords

Glycemic variability; Cardiovascular disease; Type 2 diabetes

Funding

  1. Shionogi Co., Ltd.
  2. Ministry of Education, Culture, Sports, Science and Technology [20K17542]
  3. Grants-in-Aid for Scientific Research [20K17542] Funding Source: KAKEN

Ask authors/readers for more resources

In Japanese patients with type 2 diabetes, long-term glycemic variability is associated with the risk of cardiovascular events, independent of mean-HbA1c. Variability and mean HbA1c could be important glycemic indicators in managing type 2 diabetes patients, especially for those with a mean-HbA1c of <7%.
Aims/Introduction Long-term glycemic variability is important for predicting diabetic complications, but evaluation in a Japanese population is lacking. The aim of this study was to explore the relationship between visit-to-visit glycemic variability (VVV) and cardiovascular diseases (CV) in Japanese patients with type 2 diabetes, using the prospective cohort of the EMPATHY trial. Materials and Methods Among 4532 participants with at least three HbA1c measurements, VVV was defined using the coefficient of variation (CV-HbA1c). The outcomes were the composite cardiovascular endpoints, including cardiac, cerebral, renal, and vascular events. The odds ratios (ORs) for the development of outcomes were estimated by using logistic regression models. Results During a median follow-up of 38 months, 190 subjects developed CV events. The risk of developing CV events increased significantly with increasing quintile of CV-HbA1c, after multivariable adjustment including the mean-HbA1c (OR for the fifth vs first quintile, 1.73; 95%CI, 1.03-2.91; P for trend test = 0.003). There was a stronger association between CV-HbA1c and CV events in patients with a mean-HbA1c of <7% compared with those with a mean-HbA1c of >= 7% (OR per 1 standard deviation, 1.51; 95%CI, 1.23-1.85 and 1.13; 95%CI, 0.98-1.29, respectively; P for interaction = 0.02). Conclusions Increases of VVV were associated with the risk of CV events in Japanese patients with type 2 diabetes independent of the mean-HbA1c. The long-term variability of HbA1c as well as the mean HbA1c might be an important glycemic indicator in the management of patients with type 2 diabetes, especially in those with a mean-HbA1c of <7%.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available